Cargando…
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
BACKGROUND: Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) concentration are established biomarkers in asthma, associated particularly with the risk of exacerbations. We evaluated the relationship of BEC and FeNO as complementary and independent biomarkers of severe asthma e...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702739/ https://www.ncbi.nlm.nih.gov/pubmed/31452870 http://dx.doi.org/10.1186/s13601-019-0282-7 |
_version_ | 1783445286321913856 |
---|---|
author | Price, David B. Bosnic-Anticevich, Sinthia Pavord, Ian D. Roche, Nicolas Halpin, David M. G. Bjermer, Leif Usmani, Omar S. Brusselle, Guy Ming, Simon Wan Yau Rastogi, Sarang |
author_facet | Price, David B. Bosnic-Anticevich, Sinthia Pavord, Ian D. Roche, Nicolas Halpin, David M. G. Bjermer, Leif Usmani, Omar S. Brusselle, Guy Ming, Simon Wan Yau Rastogi, Sarang |
author_sort | Price, David B. |
collection | PubMed |
description | BACKGROUND: Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) concentration are established biomarkers in asthma, associated particularly with the risk of exacerbations. We evaluated the relationship of BEC and FeNO as complementary and independent biomarkers of severe asthma exacerbations. METHODS: This observational study included data from the Optimum Patient Care Research Database. Asthma patients (18–80 years) with valid continuous data for 1 year before FeNO reading, ≥ 1 inhaled corticosteroid prescription, and BEC recorded ≤ 5 years before FeNO reading were separated into cohorts. Categorisation 1 was based on the American Thoracic Society criteria for elevated FeNO concentration (high: ≥ 50 ppb; non-high: < 25 ppb) and BEC (high: ≥ 0.300 × 10(9) cells/L; non-high: < 0.300 × 10(9) cells/L). Categorisation 2 (FeNO concentration, high: ≥ 35 ppb; non-high: < 35 ppb) was based on prior research. Reference groups included patients with neither biomarker raised. RESULTS: In categorisation 1, patients with either high FeNO or high BEC (n = 200) had a numerically greater exacerbation rate (unadjusted rate ratio, 1.31 [95% confidence interval: 0.97, 1.76]) compared with patients in the reference group. Combination of high FeNO and high BEC (n = 27) resulted in a significantly greater exacerbation rate (3.67 [1.49, 9.04]). Similarly, for categorisation 2, when both biomarkers were raised (n = 53), a significantly greater exacerbation rate was observed (1.72 [1.00, 2.93]). CONCLUSION: The combination of high FeNO and high BEC was associated with significantly increased severe exacerbation rates in the year preceding FeNO reading, suggesting that combining FeNO and BEC measurements in primary care may identify asthma patients at risk of exacerbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13601-019-0282-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6702739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67027392019-08-26 Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations Price, David B. Bosnic-Anticevich, Sinthia Pavord, Ian D. Roche, Nicolas Halpin, David M. G. Bjermer, Leif Usmani, Omar S. Brusselle, Guy Ming, Simon Wan Yau Rastogi, Sarang Clin Transl Allergy Research BACKGROUND: Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) concentration are established biomarkers in asthma, associated particularly with the risk of exacerbations. We evaluated the relationship of BEC and FeNO as complementary and independent biomarkers of severe asthma exacerbations. METHODS: This observational study included data from the Optimum Patient Care Research Database. Asthma patients (18–80 years) with valid continuous data for 1 year before FeNO reading, ≥ 1 inhaled corticosteroid prescription, and BEC recorded ≤ 5 years before FeNO reading were separated into cohorts. Categorisation 1 was based on the American Thoracic Society criteria for elevated FeNO concentration (high: ≥ 50 ppb; non-high: < 25 ppb) and BEC (high: ≥ 0.300 × 10(9) cells/L; non-high: < 0.300 × 10(9) cells/L). Categorisation 2 (FeNO concentration, high: ≥ 35 ppb; non-high: < 35 ppb) was based on prior research. Reference groups included patients with neither biomarker raised. RESULTS: In categorisation 1, patients with either high FeNO or high BEC (n = 200) had a numerically greater exacerbation rate (unadjusted rate ratio, 1.31 [95% confidence interval: 0.97, 1.76]) compared with patients in the reference group. Combination of high FeNO and high BEC (n = 27) resulted in a significantly greater exacerbation rate (3.67 [1.49, 9.04]). Similarly, for categorisation 2, when both biomarkers were raised (n = 53), a significantly greater exacerbation rate was observed (1.72 [1.00, 2.93]). CONCLUSION: The combination of high FeNO and high BEC was associated with significantly increased severe exacerbation rates in the year preceding FeNO reading, suggesting that combining FeNO and BEC measurements in primary care may identify asthma patients at risk of exacerbations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13601-019-0282-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-21 /pmc/articles/PMC6702739/ /pubmed/31452870 http://dx.doi.org/10.1186/s13601-019-0282-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Price, David B. Bosnic-Anticevich, Sinthia Pavord, Ian D. Roche, Nicolas Halpin, David M. G. Bjermer, Leif Usmani, Omar S. Brusselle, Guy Ming, Simon Wan Yau Rastogi, Sarang Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title_full | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title_fullStr | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title_full_unstemmed | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title_short | Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
title_sort | association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702739/ https://www.ncbi.nlm.nih.gov/pubmed/31452870 http://dx.doi.org/10.1186/s13601-019-0282-7 |
work_keys_str_mv | AT pricedavidb associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT bosnicanticevichsinthia associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT pavordiand associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT rochenicolas associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT halpindavidmg associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT bjermerleif associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT usmaniomars associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT brusselleguy associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT mingsimonwanyau associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations AT rastogisarang associationofelevatedfractionalexhalednitricoxideconcentrationandbloodeosinophilcountwithsevereasthmaexacerbations |